Delivery Order SPE2DB25D3404-SPE2DB25FUPDC
Award Date 7/7/25
Potential Completion Date 7/8/25
Potential Value $4.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $3,436.80 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 100 capsules of the prescription medication lisdexamfetamine 20 mg. The contract has an ultimate completion date of July 3, 2025 and is not set aside for any socioeconomic category. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- This is a $3,756.77 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 100-count bottles of the prescription drug lisdexamfetamine 30 mg capsules. The contract has an ultimate completion date of July 8, 2025 and is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor and holds a significant $999,999,999.00 Indefinite...
- This is a $3,264.08 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of the medication lisdexamfetamine 20 mg capsules in 90-count packages. The order has a completion date of July 7, 2025. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support...
- This is a $1,254.83 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 100 units of the medication lisdexamfetamine 30 mg capsules. The contract has a performance period ending on June 12, 2025 and does not utilize a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
- This is a $1,160.12 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 100 units of the prescription medication lisdexamfetamine 40 mg capsules. It has an ultimate completion date of July 2, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite...
- This is a $1,070.16 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 100 units of the drug lisdexamfetamine 20mg capsules, with a period of performance through May 28, 2025. This order is not associated with a set-aside program and was competed openly. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply 100-count bottles of the prescription medication lisdexamfetamine 50 mg capsules. The fixed-price contract has a ceiling value of $2,652.70 and a completion date of June 18, 2025. The contract is not set aside for any specific business size or socioeconomic category. AmerisourceBergen Drug Corp holds a substantial Indefinite...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 100-count bottles of the medication Lisdexamfetamine 40 mg capsules, with a ceiling value of $1,859.10 and a period of performance ending on May 6, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a larger...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 100 units of the prescription medication Lisdexamfetamine 40 mg capsules. The contract has a firm fixed price of $18,118.64 and a performance period ending on June 18, 2025. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,704.52, is for the supply of lisdexamfetamine 30 mg capsules in 100-count bottles. The contract is a firm-fixed-price delivery order with an ultimate completion date of January 28, 2025. This contract award is not associated with a set-aside program and is part of a larger Indefinite...